Highly-sensitive troponin I is increased in patients with gynecological cancers

Observational OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-12 ⓘ

This study investigated elevated levels of highly-sensitive troponin I in patients diagnosed with gynecological cancers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVES: To investigate troponin I (TnI) in patients with gynecological cancers. METHODS: Highly-sensitive (HS) and conventional TnI were measured in 25 patients with untreated ovarian cancer, 25 with endometriosis and 25 with benign masses. RESULTS: Both HS and conventional TnI were increase in cancer patients. Values above the cut-off were found in 44% and 16% cancer patients using HS and conventional TnI methods, respectively. CONCLUSIONS: Cardiac involvement is frequent in patients with gynecological cancers and should be preferably assessed using HS troponin immunoassays.

My notes (saved in your browser only)

MeSH descriptors

Genital Neoplasms, Female Immunoassay Troponin I Adult Adult Female Female Genital Neoplasms, Female Genital Neoplasms, Female Humans Humans Immunoassay Immunoassay Middle Aged Middle Aged Sensitivity and Specificity Sensitivity and Specificity Troponin I Troponin I

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

References (15)

Cited by (1)

Source provenance

europepmc
last seen: 2026-10-20T06:13:28.455750+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:11:59.585523+00:00
unpaywall
last seen: 2026-10-20T06:27:24.728081+00:00
License: CC0 · commercial use OK